Once-daily dosing of nevirapine in HAARTCLOTET, Bonaventura.Journal of antimicrobial chemotherapy (Print). 2008, Vol 61, Num 1, pp 13-16, issn 0305-7453, 4 p.Article

Genetic screen for monitoring hepatitis C virus NS3 serine protease activityMARTINEZ, Miguel Angel; CLOTET, Bonaventura.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 5, pp 1760-1765, issn 0066-4804, 6 p.Article

Endoribonuclease-prepared short interfering RNAs induce effective and specific inhibition of human immunodeficiency virus type 1 replicationGIMENEZ-BARCONS, Mireia; CLOTET, Bonaventura; ANGEL MARTINEZ, Miguel et al.Journal of virology. 2007, Vol 81, Num 19, pp 10680-10686, issn 0022-538X, 7 p.Article

Fitness landscape of human immunodeficiency virus type 1 protease quasispeciesFERNANDEZ, Guerau; CLOTET, Bonaventura; ANGEL MARTINEZ, Miguel et al.Journal of virology. 2007, Vol 81, Num 5, pp 2485-2496, issn 0022-538X, 12 p.Article

Clinical Implications of Genotypic Resistance to the Newer Antiretroviral Drugs in HIV-1―Infected Patients with Virological FailureLLIBRE, Josep M; SCHAPIRO, Jonathan M; CLOTET, Bonaventura et al.Clinical infectious diseases. 2010, Vol 50, Num 6, pp 872-881, issn 1058-4838, 10 p.Article

Genetic screen for monitoring severe acute respiratory syndrome coronavirus 3C-like proteasePARERA, Mariona; CLOTET, Bonaventura; MARTINEZ, Miguel Angel et al.Journal of virology. 2004, Vol 78, Num 24, pp 14057-14061, issn 0022-538X, 5 p.Article

Benefits and concerns of simplification strategies in HIV-infected patientsNEGREDO, Eugènia; BONJOCH, Anna; CLOTET, Bonaventura et al.Journal of antimicrobial chemotherapy (Print). 2006, Vol 58, Num 2, pp 235-242, issn 0305-7453, 8 p.Article

Development of resistance to VIR-353 with cross-resistance to the natural HIV-1 entry virus inhibitory peptide (VIRIP)GONZALEZ, Emmanuel; BALLANA, Ester; CLOTET, Bonaventura et al.AIDS (London). 2011, Vol 25, Num 13, pp 1575-1583, issn 0269-9370, 9 p.Article

Lack of evidence for protease evolution in HIV-1infected patients after 2 years of successful highly active antiretroviral therapyPARERA, Mariona; IBANEZ, Angela; CLOTET, Bonaventura et al.The Journal of infectious diseases. 2004, Vol 189, Num 8, pp 1444-1451, issn 0022-1899, 8 p.Article

Compromised immunologic recovery in treatment-experienced patients with HIV infection receiving both tenofovir disoproxil fumarate and didanosine in the TORO studiesNEGREDO, Euyènia; BONJOCH, Anna; PAREDES, Roger et al.Clinical infectious diseases. 2005, Vol 41, Num 6, pp 901-905, issn 1058-4838, 5 p.Article

Safety of etravirine in HIV-1/hepatitis B and/or C virus co-infected patients: pooled 96 week results from the Phase III DUET trialsCLOTET, Bonaventura; CLUMECK, Nathan; KATLAMA, Christine et al.Journal of antimicrobial chemotherapy (Print). 2010, Vol 65, Num 11, pp 2450-2454, issn 0305-7453, 5 p.Article

Alleles at rs4273729 in the chromosome 6 do not predict response to peg-interferon-α and ribavirin therapy in hepatitis C virus/HIV-1-coinfected patientsFRANCO, Sandra; TURAL, Cristina; CLOTET, Bonaventura et al.AIDS (London). 2012, Vol 26, Num 15, pp 1973-1974, issn 0269-9370, 2 p.Article

Clinical management of HIV-1 resistancePAREDES, Roger; CLOTET, Bonaventura.Antiviral research. 2010, Vol 85, Num 1, pp 245-265, issn 0166-3542, 21 p.Article

Therapeutic management of bone demineralization in the HIV-infected populationNEGREDO, Eugènia; MARTINEZ, Eva; CINQUEGRANA, Denise et al.AIDS (London). 2007, Vol 21, Num 6, pp 657-663, issn 0269-9370, 7 p.Article

HIV- 1 resistance to the gp41-dependent fusion inhibitor C-34ARMAND-UGON, Mercedes; GUTIERREZ, Arantxa; CLOTET, Bonaventura et al.Antiviral research. 2003, Vol 59, Num 2, pp 137-142, issn 0166-3542, 6 p.Article

Immunological and virological study of enfuvirtide-treated HIV-positive patientsBARRETINA, Jordi; BLANCO, Julia; BONJOCH, Anna et al.AIDS (London). 2004, Vol 18, Num 12, pp 1673-1682, issn 0269-9370, 10 p.Article

New antiretroviral drugs and approaches to HIV treatmentPAREDES, Roger; CLOTET, Bonaventura.AIDS (Supplement). 2003, Vol 17, pp S85-S96, issn 1350-2840, SUP4Article

Herb-Drug Interaction between Echinacea purpurea and Etravirine in HIV-Infected PatientsMOLTO, Jose; VALLE, Marta; MIRANDA, Cristina et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 10, pp 5328-5331, issn 0066-4804, 4 p.Article

Compensatory mutations rescue the virus replicative capacity of VIRIP-resistant HIV-1GONZALEZ-ORTEGA, Emmanuel; BALLANA, Ester; BADIA, Roger et al.Antiviral research. 2011, Vol 92, Num 3, pp 479-483, issn 0166-3542, 5 p.Article

Role of viral kinetics under HCV therapy in HIV/HCV-coinfected patientsLUIS BALLESTEROS, Angel; FUSTER, Daniel; PLANAS, Ramon et al.Journal of antimicrobial chemotherapy (Print). 2005, Vol 55, Num 6, pp 824-827, issn 0305-7453, 4 p.Article

Lopinavir/ritonavir monotherapy as a simplification strategy in routine clinical practiceMOLTO, José; RAMON SANTOS, José; NEGREDO, Eugenia et al.Journal of antimicrobial chemotherapy (Print). 2007, Vol 60, Num 2, pp 436-439, issn 0305-7453, 4 p.Article

Lack of longitudinal intrapatient correlation between p24 antigenemia and levels of human immunodeficiency virus (HIV) type 1 RNA in patients with chronic HIV infection during structured treatment interruptionsPRADO, Julia G; SHINTANI, Ayumi; BOFILL, Margarita et al.Journal of clinical microbiology (Print). 2004, Vol 42, Num 4, pp 1620-1625, issn 0095-1137, 6 p.Article

IFNL4 ss469415590 variant is a better predictor than rs12979860 of pegylated interferon-alpha/ ribavirin therapy failure in hepatitis C virus/HIV-1 coinfected patientsFRANCO, Sandra; APARICIO, Ester; PARERA, Mariona et al.AIDS (London). 2014, Vol 28, Num 1, pp 133-136, issn 0269-9370, 4 p.Article

Rare LEDGF/p75 genetic variants in white long-term nonprogressor HIV+ individualsBALLANA, Ester; GONZALO, Encarna; GRAU, Eulàlia et al.AIDS (London). 2012, Vol 26, Num 4, pp 527-528, issn 0269-9370, 2 p.Article

Evolution of the human immunodeficiency virus type 1 protease: effects on viral replication capacity and protease robustnessCAPEL, Elena; MARTRUS, Glòria; PARERA, Mariona et al.Journal of general virology. 2012, Vol 93, pp 2625-2634, issn 0022-1317, 10 p., 12Article